Unwrap the best of pharma in 2024 - European Medical Journal

Unwrap the best of pharma in 2024

Welcome to Unwrapped 2024, EMJ GOLD’s festive content series. Challenge yourself with word puzzles and brain teasers, explore this year’s top content and reflect on the year gone by
Join us for a three-part series adding a festive twist to our usual pharma content. In this edition: a crossword on the top mergers and acquisitions of 2024, a riddle to test your knowledge and the year’s most popular podcast. Like the idea of Unwrapped? Stay tuned for the next two installments.

Crossword Challenge

In 2024, the pharma industry’s mergers and acquisitions space has been dominated by smaller deals, but can you name some of the companies that have been involved in M&As this year?

Festive Brain Teaser

Two pioneers of a groundbreaking feat,
With algorithms that no one can beat.
They made proteins speak in ways we know,
Who are the scientists leading the show?

Click to reveal the answer:

David Baker and Demis Hassabis, Winners, 2024 Nobel Prize in Chemistry

Most Listened to Podcast in 2024

Astellas’ Tadaaki Taniguchi on how to challenge the status quo

 

Dr Tadaaki Taniguchi, Chief Medical Officer and Head of Medical and Development at Astellas Pharma, shares how he challenges the status quo in pharma. He also reflects on how his surgical oncology background shapes his leadership and the power of collaboration to improve patient outcomes.

Watch now >